NeuralCipher Research overview
The text below is the source article’s original abstract under a verified reuse license. cc by
Abstract Neurodegenerative diseases such as Alzheimer’s and Parkinson’s are characterized by the death of neurons in specific brains. α-synuclein (α-Syn) is a key factor in Parkinson’s disease (PD), forming toxic fibrils when misfolded. Natural products, such as Boswellia serrata, have shown promise in treating neurodegenerative diseases. However, the poor pharmacological performance of Boswellia acids (BAs) limits their effectiveness. Enhancing the bioavailability of BAs through nanocarriers could be a solution. This study explores the potential of β-Boswellic acid conjugated to gold nanoparticles (GNPs) as a novel PD treatment. Covalent and noncovalent conjugations of β-Boswellic acid to GNPs (GNP-BA) were developed to study their impact on α-Syn fibrillation in vitro. The successful synthesis of spherical GNPs (
Scientific assessment
Research question
Assess the question within the original study’s scope.
Methods & sample
Check the source article for study design and sample details.
Key findings
An editorially approved findings summary is not yet published for this record.
Limitations
Generalizability, bias and clinical meaning require separate assessment.
Methods, samples and clinical conclusions are not inferred from bibliographic metadata.